Universal Beteiligungs und Servicegesellschaft mbH Acquires 41,563 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Universal Beteiligungs und Servicegesellschaft mbH grew its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 2.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,529,120 shares of the real estate investment trust's stock after acquiring an additional 41,563 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.22% of Healthpeak Properties worth $30,919,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of DOC. Mizuho Bank Ltd. acquired a new position in shares of Healthpeak Properties during the 4th quarter valued at $28,000. Future Financial Wealth Managment LLC purchased a new stake in shares of Healthpeak Properties in the first quarter valued at $30,000. S.A. Mason LLC grew its stake in Healthpeak Properties by 160.9% during the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after acquiring an additional 925 shares in the last quarter. Covestor Ltd grew its position in Healthpeak Properties by 173.8% during the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after purchasing an additional 1,152 shares in the last quarter. Finally, Beacon Capital Management LLC increased its stake in shares of Healthpeak Properties by 138.3% in the first quarter. Beacon Capital Management LLC now owns 1,816 shares of the real estate investment trust's stock worth $37,000 after acquiring an additional 1,054 shares during the last quarter. Institutional investors own 93.57% of the company's stock.

Analyst Ratings Changes

Several research firms recently issued reports on DOC. Evercore ISI reduced their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Robert W. Baird dropped their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 29th. Wedbush decreased their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Finally, Argus reiterated a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a report on Tuesday, April 29th. One research analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and an average price target of $23.27.

Insider Buying and Selling

In related news, Director Tommy G. Thompson acquired 5,777 shares of the firm's stock in a transaction on Wednesday, May 28th. The shares were purchased at an average price of $17.27 per share, with a total value of $99,768.79. Following the acquisition, the director directly owned 144,290 shares in the company, valued at $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director John T. Thomas bought 4,200 shares of Healthpeak Properties stock in a transaction dated Monday, April 28th. The shares were bought at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director directly owned 813,566 shares of the company's stock, valued at $14,514,017.44. This represents a 0.52% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 29,764 shares of company stock worth $521,909 in the last three months. Insiders own 0.23% of the company's stock.

Healthpeak Properties Price Performance

NYSE:DOC traded down $1.24 during mid-day trading on Friday, hitting $17.64. The company's stock had a trading volume of 16,243,151 shares, compared to its average volume of 5,871,287. The company has a market capitalization of $12.25 billion, a price-to-earnings ratio of 73.48, a P/E/G ratio of 2.00 and a beta of 1.03. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.01. Healthpeak Properties, Inc. has a fifty-two week low of $16.64 and a fifty-two week high of $23.26. The stock has a fifty day moving average of $17.69 and a 200-day moving average of $18.84.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 1.83% and a net margin of 5.90%. The business had revenue of $694.35 million during the quarter, compared to the consensus estimate of $697.14 million. During the same quarter last year, the company earned $0.45 EPS. Healthpeak Properties's revenue was down .2% on a year-over-year basis. As a group, equities analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Friday, September 19th will be given a $0.1017 dividend. The ex-dividend date of this dividend is Friday, September 19th. This represents a $1.22 dividend on an annualized basis and a yield of 6.92%. Healthpeak Properties's dividend payout ratio (DPR) is presently 508.33%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.